Forward Therapeutics Announces $50 Million Series A Financing To Advance Next-Generation Small Molecule Immune Therapies
Amount Raised
$50 Million
Round Type
Series A
Investors
Description
Forward Therapeutics, Inc., a biopharmaceutical company developing next-generation small molecule therapies for chronic immunological and inflammatory disorders, today announced a $50 million Series A financing. The financing was led by BVF Partners LP with participation from other leading life sciences investors RA Capital Management and OrbiMed.
Quick answer
Forward Therapeutics raised $50 Million in a Series A round, dated November 8, 2023. Investors: Orbi Med, RA Capital Management and BVF Partners LP. Forward Therapeutics is based in Palm Beach Gardens, Florida, United States.
- How much did Forward Therapeutics raise?
- Forward Therapeutics raised $50 Million in a Series A round on November 8, 2023.
- Who invested in Forward Therapeutics?
- Orbi Med, RA Capital Management and BVF Partners LP are named as investors in this round.
- What does Forward Therapeutics do?
- Forward Tx is a small molecule biotech focused on creating transformative immunology drugs.
- Where is Forward Therapeutics based and how big is it?
- Forward Therapeutics is based in Palm Beach Gardens, Florida, United States.
- Who are the decision-makers at Forward Therapeutics?
- Fundz holds 1 contact at Forward Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Forward Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $700K on December 8, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- Acasti raised $7.5M (Post-IPO Equity) on September 26, 2023.
- Acasti raised $7.5M on September 25, 2023.
- Sudo Biosciences raised $116M (Series B) on December 20, 2023.
- Sudo Biosciences raised $53M on December 15, 2023.
Who to call at Forward Therapeutics, and when
A new round usually means Forward Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Forward Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Forward Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Forward Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Forward Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansForward Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.